Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

First Line Sorafenib Treatment for Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis.

Kocsis J, Szekanecz É, Bassam A, Uhlyarik A, Pápai Z, Rubovszky G, Mezősi E, Rucz K, Garai I, Nagy E, Uray I, Horváth Z.

Exp Clin Endocrinol Diabetes. 2018 Mar 5. doi: 10.1055/s-0044-100378. [Epub ahead of print]

PMID:
29506310
2.

Comparison of peripheral quantitative computed tomography forearm bone density versus DXA in rheumatoid arthritis patients and controls.

Juhász B, Gulyás K, Horváth Á, Pethő Z, Bhattoa HP, Váncsa A, Szekanecz É, Horváth C, Kocsis J, Horváth Z, Hodosi K, Szántó S, Szűcs G, Szekanecz Z.

Osteoporos Int. 2017 Apr;28(4):1271-1277. doi: 10.1007/s00198-016-3850-x. Epub 2016 Dec 10.

PMID:
27942777
3.

[Physiotherapy of cancer patients].

Gomez I, Szekanecz É, Szekanecz Z, Bender T.

Orv Hetil. 2016 Jul;157(31):1224-31. doi: 10.1556/650.2016.30502. Review. Hungarian.

PMID:
27476518
4.

Malignancies associated with systemic sclerosis.

Szekanecz É, Szamosi S, Horváth Á, Németh Á, Juhász B, Szántó J, Szücs G, Szekanecz Z.

Autoimmun Rev. 2012 Oct;11(12):852-5. doi: 10.1016/j.autrev.2012.02.021. Epub 2012 Mar 5. Review.

PMID:
22410174
5.

Malignancies in autoimmune rheumatic diseases - a mini-review.

Szekanecz Z, Szekanecz E, Bakó G, Shoenfeld Y.

Gerontology. 2011;57(1):3-10. doi: 10.1159/000314634. Epub 2010 May 7. Review.

6.

Recurrent laryngeal nerve paralysis due to subclinical Lyme borreliosis.

Karosi T, Rácz T, Szekanecz E, Tóth A, Sziklai I.

J Laryngol Otol. 2010 Mar;124(3):336-8. doi: 10.1017/S0022215109990867. Epub 2009 Sep 10.

PMID:
19740453
7.

Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.

Szekanecz E, Szucs G, Szekanecz Z, Tarr T, Antal-Szalmás P, Szamosi S, Szántó J, Kiss E.

J Autoimmun. 2008 Dec;31(4):372-6. doi: 10.1016/j.jaut.2008.08.008. Epub 2008 Oct 15.

PMID:
18926664
8.

Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis.

Szekanecz E, Szamosi S, Gergely L, Keszthelyi P, Szekanecz Z, Szucs G.

Clin Rheumatol. 2008 Sep;27(9):1163-6. doi: 10.1007/s10067-008-0925-x. Epub 2008 May 24.

PMID:
18500435
9.

Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.

András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, Dankó K.

J Rheumatol. 2008 Mar;35(3):438-44. Epub 2008 Jan 15.

PMID:
18203322
10.

Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?

Szekanecz E, Sándor Z, Antal-Szalmás P, Soós L, Lakos G, Besenyei T, Szentpétery A, Simkovics E, Szántó J, Kiss E, Koch AE, Szekanecz Z.

Ann N Y Acad Sci. 2007 Jun;1108:359-71.

11.

Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center.

Tarr T, Gyorfy B, Szekanecz E, Bhattoa HP, Zeher M, Szegedi G, Kiss E.

Ann N Y Acad Sci. 2007 Jun;1108:76-82.

PMID:
17893972
12.

[The occurrence of malignancies in a Hungarian lupus population].

Tarr T, Szekanecz E, Zeher M, Szegedi G, Kiss E.

Orv Hetil. 2006 Nov 19;147(46):2229-33. Hungarian.

PMID:
17396395
13.

Malignancies and soluble tumor antigens in rheumatic diseases.

Szekanecz E, András C, Sándor Z, Antal-Szalmás P, Szántó J, Tamási L, Kiss E, Szekanecz Z.

Autoimmun Rev. 2006 Nov;6(1):42-7. Epub 2006 Apr 19. Review.

PMID:
17110316
14.

[Current aspects of the pathogenesis and clinical characteristics of otosclerosis: possibilities of drug therapy].

Szekanecz Z, Szekanecz E, Morvai K, Rácz T, Szegedi G, Sziklai I.

Orv Hetil. 1999 Oct 31;140(44):2435-40. Review. Hungarian.

PMID:
10573986

Supplemental Content

Loading ...
Support Center